Leigh Farrell

Health Technology

Profile

Leigh Farrell formerly worked at Gene Shears Pty Ltd., as Chief Executive Officer, Biota Holdings Pty Ltd., as Vice President-Business Development, Johnson & Johnson Research Pty Ltd., as Research Manager, and Aviragen Therapeutics, Inc., as Vice President-Business Development.

Former positions of Leigh Farrell

Companies	Position	End
Aviragen Therapeutics, Inc. Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA.	Corporate Officer/Principal	-
Johnson & Johnson Research Pty Ltd.	Chief Tech/Sci/R&D Officer	-
Gene Shears Pty Ltd.	President	-
BIOTA HOLDINGS LTD.	Corporate Officer/Principal	-

See the detail of Leigh Farrell's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies